Outset Medical director granted 10,667 shares

Drexler Karen reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Drexler Karen reported acquisition or exercise transactions in this Form 4 filing.

Outset Medical, Inc. director Karen Drexler reported an equity award of common stock as compensation. She received 10,667 shares at a price of $0.00 per share, reflecting a grant rather than an open-market purchase or sale.

According to the filing, 100% of the shares underlying these RSUs will vest upon the earlier of the one-year anniversary of the grant date or the company’s next Annual Meeting of Stockholders. Following the grant, Drexler directly holds 21,317 shares of common stock and indirectly holds 2,083 shares through the Drexler Family Trust.

Insider Trade Summary

Grant/Award: 10,667 shares

Grant/Award 2 txns

Insider Drexler Karen

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	10,667	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 21,317 shares (Direct); Common Stock — 2,083 shares (Indirect, Drexler Family Trust)

Footnotes (1)

1. F1. 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Key Figures

Stock grant size: 10,667 shares Grant price: $0.00 per share Direct holdings after grant: 21,317 shares +1 more

4 metrics

Stock grant size 10,667 shares Common stock grant to director at $0.00 per share

Grant price $0.00 per share Price per share for the equity award

Direct holdings after grant 21,317 shares Common stock held directly by Karen Drexler after transaction

Indirect holdings after grant 2,083 shares Common stock held indirectly via Drexler Family Trust

Key Terms

RSUs, Annual Meeting of Stockholders, Grant, award, or other acquisition, Drexler Family Trust

4 terms

RSUs financial

"100% of the shares underlying these RSUs will vest upon the earlier"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

Annual Meeting of Stockholders regulatory

"the date of the Issuer's next Annual Meeting of Stockholders"

Grant, award, or other acquisition financial

"transaction_code_description":"Grant, award, or other acquisition"

Drexler Family Trust financial

"nature_of_ownership":"Drexler Family Trust"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Outset Medical (OM) report for Karen Drexler?

Outset Medical reported that director Karen Drexler received a grant of 10,667 shares of common stock as compensation, at a price of $0.00 per share. This is an equity award, not an open-market stock purchase or sale.

How many Outset Medical shares does Karen Drexler hold after this Form 4?

After the reported grant, Karen Drexler holds 21,317 shares of Outset Medical common stock directly and 2,083 shares indirectly via the Drexler Family Trust. These positions reflect her ownership as shown in the Form 4 filing.

Is the 10,667-share transaction for Outset Medical (OM) an open-market buy or sell?

The 10,667-share transaction is a grant of common stock at $0.00 per share, not an open-market buy or sell. It represents compensation awarded to director Karen Drexler rather than a discretionary stock market transaction.

What are the vesting terms of Karen Drexler’s new Outset Medical equity award?

All shares underlying the RSUs will vest 100% on the earlier of the one-year anniversary of the grant date or the date of Outset Medical’s next Annual Meeting of Stockholders. Vesting determines when Drexler actually earns the shares free of restrictions.

How are some of Karen Drexler’s Outset Medical (OM) shares held?

In addition to her directly held shares, 2,083 shares of Outset Medical common stock are held indirectly through the Drexler Family Trust. The Form 4 identifies this trust as the nature of ownership for those indirectly held shares.

What does transaction code “A” mean in this Outset Medical Form 4?

Transaction code “A” on the Outset Medical Form 4 indicates a grant, award, or other acquisition of common stock. In this case, it reflects a 10,667-share equity award to director Karen Drexler as part of her compensation, not a market trade.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/05/2026 - 06:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Drexler Karen

(Last) (First) (Middle)

3052 ORCHARD DRIVE

(Street)

SAN JOSE CALIFORNIA 95134

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Outset Medical, Inc. [ OM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/04/2026		A		10,667(1)	A	$0.0	21,317	D
Common Stock								2,083	I	Drexler Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

	By: John L Brottem For: Karen Drexler	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)